SLC35A2 and neoplasm: However, this analysis also revealed differences in the overall levels of UGT expression between mutated and unmutated tumor groups (Table S9), suggesting that any comparison of clinicopathological features and clinical outcomes (e.g., survival time) between these groups could be confounded by differing UGT expression levels.